Live Science on MSN8d
Acromegaly: A disease that causes adults to grow uncontrollably
Patients with acromegaly make too much growth hormone, which causes them to grow disproportionately large bones, organs and ...
Endocrinology Advisor2d
FDA to Review Paltusotine, an Oral Therapy for Acromegaly
The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is provided to drugs defined as being intended for the safe and effective ...
Promising Prospects for Crinetics Pharmaceuticals: Buy Rating Driven by Potential Paltusotine Approval and Expansive Pipeline
JMP Securities analyst Jonathan Wolleben has reiterated their bullish stance on CRNX stock, giving a Buy rating today.Pick the best stocks and ...
Monthly Prescribing Reference5d
FDA to Review Paltusotine, an Oral Therapy for Acromegaly
A Prescription Drug User Fee Act target date of September 25, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...